Nawab Ali Source Confirmed

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

Federal Grant PI

Professor

University of Arkansas at Little Rock

faculty

19 h-index 104 pubs 1,636 cited

Research Areas

Nanoparticles: synthesis and applications Cancer Treatment and Pharmacology Breast Cancer Treatment Studies Nanoplatforms for cancer theranostics Drug-Induced Hepatotoxicity and Protection Bone health and treatments Advanced Chemical Sensor Technologies

Links

ORCID Lab Website

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Nawab Ali's research focuses on the development and application of nanomedicine for cancer therapy, with a particular emphasis on breast cancer. His work involves designing novel nanomaterials, including ionic liquids and hydrogels, to enhance drug delivery and therapeutic efficacy. He investigates the photophysical properties of these materials for applications in photothermal therapy and combination chemo-phototherapy.

Ali's publications detail advancements in areas such as the cellular uptake of gold nanorods, the use of guar-based hydrogels for drug delivery and bone cell growth, and the creation of tumor microenvironment-triggered nanoplatforms for mild-temperature photothermal therapy. His research also explores the tunable cytotoxicity and selectivity of ionic liquids combined with dyes for potential therapeutic uses.

He holds a federal grant from the National Science Foundation (NSF) for "Nano Drug Enabled Cancer Therapy," for which he serves as Principal Investigator. Ali has a notable publication record, with 104 total publications and an h-index of 19, accumulating over 1,600 citations. He actively collaborates with researchers at the University of Arkansas at Little Rock, including Noureen Siraj, Mujeebat Bashiru, Tansel Karabacak, and Quinshell Smith.

Metrics

h-index: 19
Publications: 104
Citations: 1,636

Selected Publications

Dichloroacetic Acid Enhances Photodynamic Therapy-Induced Regulated Cell Death in PANC-1 Pancreatic Cancer Cell Line (2025) DOI
95 Targeting Multiple Cancer Hallmarks with Rapamycin-Loaded Gold Nanoparticles—GE11 Peptide Conjugate: A Proteomic Analysis of Pathway Suppression and Cell Death Induction (2025) DOI
The Underlying Mechanisms and Emerging Strategies to Overcome Resistance in Breast Cancer (2025) DOI
Targeted Delivery of Rapamycin via Epidermal Growth Factor Receptors in Pancreatic Cancer Cells Inhibits Cell Proliferation and Induces Apoptosis (2025) DOI
Effect of Blood Flow Restriction on Serum Brain-Derived Neurotrophic Factor (2025) DOI
Serum tissue plasminogen activator after cycling with blood flow restriction (2025) DOI
IONIC NANOMEDICINE STRATEGY TO DEVELOP EFFECTIVE CHEMO-PTT COMBINATION CANCER THERAPEUTICS (2024) DOI
Encapsulation of Inositol Hexakisphosphate with Chitosan via Gelation to Facilitate Cellular Delivery and Programmed Cell Death in Human Breast Cancer Cells (2024) DOI
Interrogating the Role of Endocytosis Pathway and Organelle Trafficking for Doxorubicin-Based Combination Ionic Nanomedicines (2024) DOI
Doxorubicin-Based Ionic Nanomedicines for Combined Chemo-Phototherapy of Cancer (2024) DOI
Cationic Porphyrin-Based Ionic Nanomedicines for Improved Photodynamic Therapy (2023) DOI
Guar-Based Injectable Hydrogel for Drug Delivery and In Vitro Bone Cell Growth (2023) DOI
Correction: Enhancing antibacterial property of aluminum foil by nanostructuring its surface through a steam treatment (2023) DOI
Antibacterial efficacy of surface aluminum oxide nanostructures produced by hot water treatment (2023) DOI
Enhancing antibacterial property of aluminum foil by nanostructuring its surface through a steam treatment (2023) DOI